Spyre Therapeutics
SYRE
#4931
Rank
A$2.23 B
Marketcap
$38.13
Share price
3.16%
Change (1 day)
42.71%
Change (1 year)

EPS for Spyre Therapeutics (SYRE)

EPS in 2024 (TTM): -$109.38

According to Spyre Therapeutics's latest financial reports the company's current EPS (TTM) is -$115.34. In 2023 the company made an earnings per share (EPS) of -$78.49 a decrease over its 2022 EPS that were of -$39.55.

EPS history for Spyre Therapeutics from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-$109.3839.35%
2023-$78.4998.46%
2022-$39.55-1%
2021-$39.95-34.21%
2020-$60.72-37.96%
2019-$97.8815.02%
2018-$85.0918.33%
2017-$71.91-18.92%
2016-$88.69120.2%
2015-$40.28-33.55%
2014-$60.61